Innocrin Pharmaceuticals

Innocrin Pharmaceuticals

Novel, best-in-class oral inhibitors of cyp17 lyase, a validated enzyme target for the treatment

Innocrin Pharmaceuticals company information

Edit
Growth stage
Edit
Innocrin Pharmaceuticals team Edit
Are you an employee or an investor of this company?
Add your profile